健康未接种印度成人中23种肺炎球菌疫苗型荚膜多糖基线IgG抗体水平估计
研究采用WHO推荐的ELISA法,首次检测108名健康未接种印度成人对23种肺炎球菌疫苗型荚膜多糖的基线IgG抗体水平。中位基线IgG浓度范围为0.54 µg/mL至12.35 µg/mL,最高见于14、19A和33F型,最低见于3、4和5型。约79%的研究人群对74%的荚膜多糖型中位基线IgG水平≥1.3 µg/mL。
要点
- 中位基线IgG浓度范围为0.54 µg/mL至12.35 µg/mL。
- 最高基线荚膜多糖特异性IgG见于14、19A和33F型。
- 最低基线IgG见于3、4和5型。
核心结论
- 在未接种成人中观察到可观的基线抗体水平,该研究有助于弥补基线免疫原性数据缺口,并可能为评估印度成人对肺炎球菌疫苗接种的免疫应答提供有价值的基础。
研究设计与样本
- 研究采用WHO推荐的ELISA法,测量了108名健康未接种印度成人的基线IgG抗体水平。
主要发现
- 中位基线IgG浓度范围为0.54 µg/mL至12.35 µg/mL。
- 最高基线荚膜多糖特异性IgG见于14、19A和33F型,最低基线IgG见于3、4和5型。
- 约79%的研究人群对74%的荚膜多糖型中位基线IgG水平≥1.3 µg/mL。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since immunological responses to pneumococcal vaccines are assessed by a fold-increase in antibody levels relative to pre-immunization levels, it is therefore critical to determine baseline antibody levels to establish putative threshold as a measure of normal response. Herein, for the first time, we measured baseline IgG antibody levels in 108 healthy unvaccinated Indian adults using WHO-recommended ELISA. Median baseline IgG concentration ranged between 0.54 µg/mL to 12.35 µg/mL. Highest levels of baseline capsule polysaccharide (cPS)-specific IgG were found against types 14, 19A, and 33F. Whereas, lowest baseline IgG levels were observed against types 3, 4, and 5. Overall, ∼79% of study population had median baseline IgG levels ≥1.3 µg/mL against 74% of cPS's. Substantial baseline antibody levels in unvaccinated adults were observed. The study would be critical in bridging gaps in baseline immunogenicity data and may offer a valuable foundation for evaluating immune response of Indian adults to pneumococcal vaccination.
引用
- Govindan V, Ganaie FA, Ramakrishnan SM, et al. Estimation of baseline IgG antibody levels to 23 pneumococcal vaccine-type capsular polysaccharides in healthy vaccine naïve Indian adults. Vaccine. 2023. PMID: 37173269. doi:10.1016/j.vaccine.2023.04.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。